| Bayesian survival analysis JG Ibrahim, MH Chen, D Sinha, JG Ibrahim, MH Chen Springer, 2001 | 1962 | 2001 |
| Monte Carlo methods in Bayesian computation MH Chen, QM Shao, JG Ibrahim Springer Science & Business Media, 2012 | 1509 | 2012 |
| Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences A Zhu, JG Ibrahim, MI Love Bioinformatics 35 (12), 2084-2092, 2019 | 1286 | 2019 |
| High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190 JM Kirkwood, JG Ibrahim, VK Sondak, J Richards, LE Flaherty, ... Journal of clinical oncology 18 (12), 2444-2458, 2000 | 1183 | 2000 |
| High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma … JM Kirkwood, JG Ibrahim, JA Sosman, VK Sondak, SS Agarwala, ... Journal of Clinical Oncology 19 (9), 2370-2380, 2001 | 1127 | 2001 |
| Power prior distributions for regression models JG Ibrahim, MH Chen Statistical Science, 46-60, 2000 | 879 | 2000 |
| A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma JM Kirkwood, J Manola, J Ibrahim, V Sondak, MS Ernstoff, U Rao Clinical Cancer Research 10 (5), 1670-1677, 2004 | 644 | 2004 |
| Missing-data methods for generalized linear models: A comparative review JG Ibrahim, MH Chen, SR Lipsitz, AH Herring Journal of the American Statistical Association 100 (469), 332-346, 2005 | 623 | 2005 |
| A new Bayesian model for survival data with a surviving fraction MH Chen, JG Ibrahim, D Sinha Journal of the American Statistical Association 94 (447), 909-919, 1999 | 617 | 1999 |
| UGT1A1* 28 genotype and irinotecan-induced neutropenia: dose matters JM Hoskins, RM Goldberg, P Qu, JG Ibrahim, HL McLeod Journal of the National Cancer Institute 99 (17), 1290-1295, 2007 | 576 | 2007 |
| Missing data methods in longitudinal studies: a review JG Ibrahim, G Molenberghs Test 18 (1), 1-43, 2009 | 554 | 2009 |
| Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human aging Y Liu, HK Sanoff, H Cho, CE Burd, C Torrice, JG Ibrahim, NE Thomas, ... Aging cell 8 (4), 439-448, 2009 | 511 | 2009 |
| Basic concepts and methods for joint models of longitudinal and survival data JG Ibrahim, H Chu, LM Chen Journal of clinical oncology 28 (16), 2796-2801, 2010 | 504 | 2010 |
| Predictive model selection PW Laud, JG Ibrahim Journal of the Royal Statistical Society Series B: Statistical Methodology …, 1995 | 484 | 1995 |
| Use of historical control data for assessing treatment effects in clinical trials K Viele, S Berry, B Neuenschwander, B Amzal, F Chen, N Enas, B Hobbs, ... Pharmaceutical statistics 13 (1), 41-54, 2014 | 478 | 2014 |
| Incomplete data in generalized linear models JG Ibrahim Journal of the American Statistical Association 85 (411), 765-769, 1990 | 467 | 1990 |
| Estimating cure rates from survival data: an alternative to two-component mixture models AD Tsodikov, JG Ibrahim, AY Yakovlev Journal of the American Statistical Association 98 (464), 1063-1078, 2003 | 463 | 2003 |
| Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials J Manola, M Atkins, J Ibrahim, J Kirkwood Journal of Clinical Oncology 18 (22), 3782-3793, 2000 | 451 | 2000 |
| Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in … CI Falkson, J Ibrahim, JM Kirkwood, AS Coates, MB Atkins, RH Blum Journal of Clinical Oncology 16 (5), 1743-1751, 1998 | 360 | 1998 |
| Missing covariates in generalized linear models when the missing data mechanism is non‐ignorable JG Ibrahim, SR Lipsitz, MH Chen Journal of the Royal Statistical Society: Series B (Statistical Methodology …, 1999 | 356 | 1999 |
